Showing results (4361-4370 of 13,213) with videos related to

Sort By:
Pageof 1,322
Diabetes Care|April 30, 2003
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohortRichard L Klein, Steven J Hunter, Alicia J Jenkins, et al.
Diabetes Care|April 30, 2003
Modem transmission of glucose values reduces the costs and need for clinic visitsH Peter Chase, Jerusha A Pearson, Clare Wightman, et al.
Diabetes Care|April 30, 2003
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)Sander J Robins, Hanna Bloomfield Rubins, Fred H Faas, et al.
Diabetes Care|April 30, 2003
C-reactive protein and glycemic control in adults with diabetesDana E King, Arch G Mainous, Thomas A Buchanan, et al.
Diabetes Care|August 28, 2003
Costs of screening for pre-diabetes among US adults: a comparison of different screening strategiesPing Zhang, Michael M Engelgau, Rodolfo Valdez, et al.
Diabetes Care|August 28, 2003
Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Comparison of anthropometric predictors of type 2 diabetes in Pima IndiansMarshall K Tulloch-Reid, Desmond E Williams, Helen C Looker, et al.
Diabetes Care|August 28, 2003
Association between number of physician visits and influenza vaccination coverage among diabetic adults with access to careLeonard E Egede
Diabetes Care|August 28, 2003
No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitisFilip K Knop, Tina Vilsbøll, Steen Larsen, et al.
Diabetes Care|August 28, 2003
Pioglitazone reduces atherogenic dense LDL particles in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled studyKarl Winkler, Thomas Konrad, Stefanie Füllert, et al.
Diabetes Care|August 28, 2003
Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetesAriel Roguin, Werner Koch, Adnan Kastrati, et al.
Pageof 1,322